<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6B440462-479C-4195-90A9-9FB4E2320006"><gtr:id>6B440462-479C-4195-90A9-9FB4E2320006</gtr:id><gtr:firstName>Alain</gtr:firstName><gtr:otherNames>Ange-Marie</gtr:otherNames><gtr:surname>Filloux</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800171"><gtr:id>406B8D03-F08B-411C-AC2A-FD3D990C82A6</gtr:id><gtr:title>Pseudomonas aeruginosa infection: analysis of antigenic proteins of the virulence-associated type VI secretion system</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800171</gtr:grantReference><gtr:abstractText>Interaction between microbes and human hosts can range from a benign, even commensal collaboration to a competition that may turn fatal resulting in the death of the host, the bacteria or both. The outcome of the interaction is balanced by a communication/signalling game in between the host and the pathogen. Among the arsenal of communication tools used by bacteria to influence host response are secretion systems (SS), which deliver toxins to the host. The SS and the transported toxins are key players in bacterial pathogenesis. Recent studies have seen the emergence of a novel type of SS, named T6SS. Bacteria harbouring T6SS all have a life style where they live in intimate contact with a host.
Pseudomonas aeruginosa is an opportunistic pathogen. It causes urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia, bone and joint infections, gastrointestinal infections and a variety of systemic infections, particularly in immuno-suppressed patients. P. aeruginosa infection is a serious problem in patients hospitalized with cancer, cystic fibrosis, and burns. The case fatality rate in these patients is 50 percent. P. aeruginosa is the third most commonly-isolated nosocomial pathogen accounting for 10% of all hospital-acquired infections.
P. aeruginosa possesses 3 T6SS. The goal of our study is to understand the molecular mechanisms, which are involved in the T6SS functioning, knowledge applicable to other T6SS-containing bacterial pathogens. We will further use this knowledge to develop antimicrobials, which will help fighting human morbidity and mortality due to persistent bacterial infections.</gtr:abstractText><gtr:technicalSummary>The secretion process is crucial for supporting communication between the bacteria and its environment or its host. Secretion systems are considered as types in gram-negative bacteria according to their structure and mode of functioning. Recent studies have seen the emergence of a novel type of bacterial secretion machinery, the type VI secretion system (T6SS). The T6SS components are mostly original, not found in other secretion systems and they have been proposed to promote secretion of two types of proteins, namely Hcp and Vgr, whose function and host targets are still unclear.
The T6SS components are encoded within cluster of genes initially named IAHP for IcmF-associated homologous proteins, since they were systematically found associated with a gene encoding an IcmF-like component. Bacteria harbouring T6SS are all gram-negative bacteria and they all have a life style where they live in intimate contact with eukaryotic cells. The T6SS is involved in bacterial pathogenesis, usually for colonisation, virulence, cytotoxicity or intracellular multiplication. The expression of T6SS genes is induced in vivo while the bacteria colonize the host. The precise role and mode of action of the T6SS is still unknown.
Our model organism, P. aeruginosa, is found in multiple human infections and harbours 3 T6SS clusters (HSI-I to HSI-III). Whereas several T6SS components have putative function, others have not. Among these, the HsiBC and HsiFGH homologues are antigenic and produced during infection since HsiBC and HsiFG antibodies are found in sera of infected hosts. This indicates that these proteins may be secreted or cell surface exposed upon activation of the T6SS.
Our project focuses on the characterization of the antigenic P. aeruginosa T6SS proteins HsiBCFGH, and aims at unravelling their role in the T6SS function. In order to gain understanding in the function, on the one hand we will mutagenize the genes and analyse the impact on host interaction, on the other hand we will perform cristallography studies to determine whether folds in these unknown proteins could be recognized and give hints on existence of putative homologues.</gtr:technicalSummary><gtr:fund><gtr:end>2012-02-29</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-11-03</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>527454</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Structural Biology</gtr:department><gtr:description>Structral Biology of T6SS components</gtr:description><gtr:id>04464E4E-E1F7-42AB-89C2-140CA5863865</gtr:id><gtr:impact>Crystals have been obtained for subcomplex of the T6SS machinery, namely HsiE/HsiB. 3D structure has been resolved for HsiE in complex with the N terminus of HsiB, and these data have been published
The structure of the N terminal domain of ClpV has been obtained and published.
The HsiBC sub-complex is studied by CryoEM. The structure is currently refined and the 3D model shows a ring shape-like structure displaying a 12-fold symmetry.
EM images of part of the T6SS baseplate have been obtained and currently optimized</gtr:impact><gtr:outcomeId>5DD52D10820-1</gtr:outcomeId><gtr:partnerContribution>Access to structural biology facilities to develop the MRC-funded project</gtr:partnerContribution><gtr:piContribution>Access to structural biology facilities to develop the MRC-funded project.
The MRC-funded RA in my lab bridges the work of the MRC-funded RT and another technician in my lab with our collaborator working at the Centre of Structural Biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>T6SS in cystic fibrosis patients</gtr:description><gtr:id>8FAB7FAA-2C40-4958-AB3E-C47EC686B909</gtr:id><gtr:impact>Prof Jane Davis from ICL has led an initiative and we were awarded a Strategic Research Centre; by the CF Trust</gtr:impact><gtr:outcomeId>nBwG2HY2XqJ-1</gtr:outcomeId><gtr:partnerContribution>Availability of sera and mucus sample from Cystic fibrosis patients</gtr:partnerContribution><gtr:piContribution>Basic knowledge on expression and activity of the type VI secretion system in Pseudomonas aeruginosa</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Visit at FINOVI- Lyon-France-2009</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>779DB122-D795-4D07-BC09-530550F38E52</gtr:id><gtr:impact>Oral presentation entitled: Molecular mechanisms of Pseudomonas aeruginosa infections: a matter of lifestyle. The presentation included part of the work supported by the MRC grant on type VI scecretion. The audience was essentially member of the FINOVI foundation (Lyon France) which supports innovation in the field of microbial infection.

None</gtr:impact><gtr:outcomeId>0D4372BEBB3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Graduate program in Infection Biology, Biozentrum, 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C448C29E-9FBE-4F02-923A-0327AA9366C6</gtr:id><gtr:impact>Lecture on basics of the T6SS for 20 PhD student of the Biozentrum, University Basel, Switzerland

Communication on the interest to study the T6SS</gtr:impact><gtr:outcomeId>RpKduJm9kYy</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Workshop at Sanofi-Aventis-2009</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D04F1942-E429-4230-B34C-F225CDB5BF92</gtr:id><gtr:impact>30 people from the R&amp;amp;D department at Sanofi-Aventis in Toulouse (France) were trained at identifying new targets for the development of antimicrobials. I organized the workshop, and invited a series of speakers who described key virulence determinants in bacterial species. The Type VI secretion system, which is the topic of my current MRC grant, was presented as one such target.

None</gtr:impact><gtr:outcomeId>V5g7K9mD4yH</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1768908</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme grant-Structure and function of the Pseudomonas aeruginosa type VI secretion system: On the bacteriophage trail</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K001930/1</gtr:fundingRef><gtr:id>CD5231D7-E2E7-4615-BBEE-568797E0668A</gtr:id><gtr:outcomeId>ZDUnToXSGaa</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>394173</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (The fate of VgrG effector proteins in the type VI secretion process: a key issue in bacteria-host relationship)</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AA772163-F014-468B-BB7C-0688B505B45C</gtr:id><gtr:outcomeId>Wr2Ckd7P4VM0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Insitute for Life Sciences (IfLS), University Southampton</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>C5B5D1D7-90AE-4DED-803D-A76026B9AFD2</gtr:id><gtr:outcomeId>K9XUVgwPuNQ</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Antibodies directed against one of the component of the T6SS machinery</gtr:description><gtr:id>690E6BA8-2358-449B-94CB-E66E3730A08D</gtr:id><gtr:impact>Further understanding of the assembly of the T6SS machinery</gtr:impact><gtr:outcomeId>SFJ4mGV9Wq8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anti-HsiA</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibodies against core component of the T6SS machine have been generated. It includes antibodies against HsiE and HsiB.</gtr:description><gtr:id>01A99FBF-DECB-439D-9D8E-7B275B72CD10</gtr:id><gtr:impact>These antibodies allow to follow assembly of the T6SS components into the T6SS machinery, to follow their sub-cellular localization and to perform Co-IP to identify new interactants.</gtr:impact><gtr:outcomeId>KeyL41L3GvW</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Anti-HsiEB</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The T6SS has been proposed to provide a growth advantage to P. aeruginosa in polymicrobial infections. An assay has been set up to assess T6SS function in P. aeruginosa by following killing of competing bacteria (E. coli)</gtr:description><gtr:id>7E483B61-7BBB-4524-942F-19E00B7350F6</gtr:id><gtr:impact>The killing assay provides a quick and easy phenotypic assessment of T6SS function and allows to screen any potential mutant affected in the T6SS assembly process.</gtr:impact><gtr:outcomeId>gEX5vS233yW</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Bacterial Killing Assay</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>69553D2F-4019-4CD1-AA96-1744B549536B</gtr:id><gtr:title>An rhs gene linked to the second type VI secretion cluster is a feature of the Pseudomonas aeruginosa strain PA14.</gtr:title><gtr:parentPublicationTitle>Journal of bacteriology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb717bce2e3d9f5f8e2e0fd9de5431d0"><gtr:id>eb717bce2e3d9f5f8e2e0fd9de5431d0</gtr:id><gtr:otherNames>Jones C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9193</gtr:issn><gtr:outcomeId>pm_540e195e195ef11a9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>19777D91-7ED6-4395-A836-7ACB8E7347DF</gtr:id><gtr:title>Regulatory RNAs and the HptB/RetS signalling pathways fine-tune Pseudomonas aeruginosa pathogenesis.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4ec5c348384b3d4a8af84fb9edaa007"><gtr:id>a4ec5c348384b3d4a8af84fb9edaa007</gtr:id><gtr:otherNames>Bordi C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>05B95940741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8A2F403-29EB-4F75-AD77-BDD758DA2813</gtr:id><gtr:title>The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling.</gtr:title><gtr:parentPublicationTitle>Environmental microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4bcf2c877201ef3beeeece07caadb623"><gtr:id>4bcf2c877201ef3beeeece07caadb623</gtr:id><gtr:otherNames>Moscoso JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1462-2912</gtr:issn><gtr:outcomeId>pm_12945_25_21955777</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6142F388-88E7-4E98-A19E-287B081509D2</gtr:id><gtr:title>The type VI secretion system: a tubular story.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec28614d18af8fb754bb9a329fce51c8"><gtr:id>ec28614d18af8fb754bb9a329fce51c8</gtr:id><gtr:otherNames>Filloux A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>2F006385AED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6749CE35-38C8-4ED5-B60C-329FC8619CB3</gtr:id><gtr:title>The bacterial type VI secretion machine: yet another player for protein transport across membranes.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec28614d18af8fb754bb9a329fce51c8"><gtr:id>ec28614d18af8fb754bb9a329fce51c8</gtr:id><gtr:otherNames>Filloux A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>B6AA5C1DDD3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FBA80783-A936-40CD-9962-C104F461693B</gtr:id><gtr:title>Type VI secretion and anti-host effectors.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310fceb14ad5d3aa94832956db3e77a2"><gtr:id>310fceb14ad5d3aa94832956db3e77a2</gtr:id><gtr:otherNames>Hachani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>56cb2acf7a0844.17379103</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8166C52-79CC-4352-8279-AD93538DF622</gtr:id><gtr:title>The archetype Pseudomonas aeruginosa proteins TssB and TagJ form a novel subcomplex in the bacterial type VI secretion system.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ee10a352ae66384c71e1b4c683f1772"><gtr:id>6ee10a352ae66384c71e1b4c683f1772</gtr:id><gtr:otherNames>Lossi NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>pm_12945_25_22906320</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A25D7297-148B-42B8-B5A2-1798B33DE97C</gtr:id><gtr:title>Type VI secretion system in Pseudomonas aeruginosa: secretion and multimerization of VgrG proteins.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/310fceb14ad5d3aa94832956db3e77a2"><gtr:id>310fceb14ad5d3aa94832956db3e77a2</gtr:id><gtr:otherNames>Hachani A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>0FF6ECFC_30FF6ECFC_3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04F70134-8A98-43E8-A104-20EC691E11BE</gtr:id><gtr:title>Protein Secretion Systems in Pseudomonas aeruginosa: An Essay on Diversity, Evolution, and Function.</gtr:title><gtr:parentPublicationTitle>Frontiers in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ec28614d18af8fb754bb9a329fce51c8"><gtr:id>ec28614d18af8fb754bb9a329fce51c8</gtr:id><gtr:otherNames>Filloux A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1664-302X</gtr:issn><gtr:outcomeId>bhUNg66HtLV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA1D1AB0-B3E2-4E1C-85C3-FD4880D06E70</gtr:id><gtr:title>Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons.</gtr:title><gtr:parentPublicationTitle>International journal of medical microbiology : IJMM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af8e394b3d65bc645f321547a1e0ef1b"><gtr:id>af8e394b3d65bc645f321547a1e0ef1b</gtr:id><gtr:otherNames>Bleves S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1438-4221</gtr:issn><gtr:outcomeId>WwDCaJwRwxx</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F626FE29-BC33-4272-BCF9-B6062E7E6EDB</gtr:id><gtr:title>Structure-function analysis of HsiF, a gp25-like component of the type VI secretion system, in Pseudomonas aeruginosa.</gtr:title><gtr:parentPublicationTitle>Microbiology (Reading, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ee10a352ae66384c71e1b4c683f1772"><gtr:id>6ee10a352ae66384c71e1b4c683f1772</gtr:id><gtr:otherNames>Lossi NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1350-0872</gtr:issn><gtr:outcomeId>J5w7TUfwUGF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F51B7E5D-D1A6-4134-BB1B-659E9E2DB30C</gtr:id><gtr:title>The HsiB1C1 (TssB-TssC) complex of the Pseudomonas aeruginosa type VI secretion system forms a bacteriophage tail sheathlike structure.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6ee10a352ae66384c71e1b4c683f1772"><gtr:id>6ee10a352ae66384c71e1b4c683f1772</gtr:id><gtr:otherNames>Lossi NS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12945_25_23341461</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1603183F-1DF4-4FC9-A502-C35302D457B7</gtr:id><gtr:title>The second type VI secretion system of Pseudomonas aeruginosa strain PAO1 is regulated by quorum sensing and Fur and modulates internalization in epithelial cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/85e7efb3f07d2bf272bbd5009680f172"><gtr:id>85e7efb3f07d2bf272bbd5009680f172</gtr:id><gtr:otherNames>Sana TG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_12945_25_22665491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A558901A-1846-4C65-9A3B-5E90FC7348AD</gtr:id><gtr:title>Coevolution of the ATPase ClpV, the sheath proteins TssB and TssC, and the accessory protein TagJ/HsiE1 distinguishes type VI secretion classes.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ed21bbf279499dd3e114d7f8dcc16aeb"><gtr:id>ed21bbf279499dd3e114d7f8dcc16aeb</gtr:id><gtr:otherNames>F?rster A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>545b8ecaa60292.06616675</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800171</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>